Key result
Surface ECG strongly predicts response to CRT in advanced HF.
Why the study?
Resynchronization therapy is a major advancement in advanced heart failure with cardiac dyssynchrony, but not all patients respond.
Answers are grounded in this paper and cite their sources.
Surface electrocardiogram plays a pivotal role as a major predictor of response to cardiac resynchronization therapy in patients with advanced heart failure.
Heart failure affects millions of patients all over the world, and its treatment is a major clinical challenge. Cardiac dyssynchrony is common among patients with advanced heart failure. Resynchronization therapy is a major advancement in heart failure management, but unfortunately not all patients respond to this therapy. Hence, many diagnostic tests have been used to predict the response and prognosis after cardiac resynchronization therapy. In this paper we summarize the usefulness of different diagnostic modalities with special emphasis on the role of surface electrocardiogram as a major predictor of response to cardiac resynchronization therapy.
No takes yet. Share an insight, caveat, or question.
Hebaishi et al. (2013) conducted a review in Heart failure. Surface electrocardiogram was evaluated on Response to cardiac resynchronization therapy. Surface electrocardiogram serves as a major predictor of response to cardiac resynchronization therapy in patients with advanced heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: